EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines.

MLA

Nowaczyk, Joanna, et al. “EGFR Inhibitor-Induced Folliculitis Decalvans: A Case Series and Management Guidelines.” Anti-Cancer Drugs, vol. 34, no. 8, Sept. 2023, pp. 942–48. EBSCOhost, https://doi.org/10.1097/CAD.0000000000001494.

APA

Nowaczyk, J., Fret, K., Kaminska-Winciorek, G., Rudnicka, L., & Czuwara, J. (2023). EGFR inhibitor-induced folliculitis decalvans: a case series and management guidelines. Anti-Cancer Drugs, 34(8), 942–948. https://doi.org/10.1097/CAD.0000000000001494

Chicago

Nowaczyk, Joanna, Kamil Fret, Grazyna Kaminska-Winciorek, Lidia Rudnicka, and Joanna Czuwara. 2023. “EGFR Inhibitor-Induced Folliculitis Decalvans: A Case Series and Management Guidelines.” Anti-Cancer Drugs 34 (8): 942–48. doi:10.1097/CAD.0000000000001494.